Glycopyrronium
(1,1-Dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate
Drag to rotate. Structure from PubChem CID 3494.
Background
Listing
- Schedules
- Schedule 3
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
8 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Formoterol | Foradil dry, Foramet dry, Foratec dp-caps, +3 more | powder | 4 applicants | 6 registrations | S2 to S4conditions apply |
| Indacaterol | Onbrez breezhaler | 150 ug | Novartis South Africa (Pty) Ltd | 440544 | S3 to S4 |
| Glycopyrronium | Seebri breezhaler, Glenispera, Glycostom, +3 more | 0,2 mg/ml, 0,2 mg/1 ml, 0,4 mg/2 ml, 2 ml, +3 more | 6 applicants | 8 registrations | S3 |
| Glycopyrronium, indacaterol | Ultibro breezhaler | 110/ 50 μg | Novartis South Africa (Pty) Ltd | 471183 | S3 |
| Indacaterol, mometasone furoate | Atectura breezhaler, Bemrist breezhaler | 80_g, 150_g, 160_g, 320_g | Novartis South Africa (Pty) Ltd | 6 registrations | S2 to S4conditions apply |
| Glycopyrronium, indacaterol, mometasone furoate | Enerzair breezhaler, Zimbus breezhaler | 150/50/80, 150/50/160 | Novartis South Africa (Pty) Ltd | 4 registrations | S2 to S4conditions apply |
| Formoterol, glycopyrronium | Glenispera co | Not stated | Glenmark Pharmaceuticals South Africa (Pty) Ltd | 570048 | S3 to S4 |
| Budesonide, formoterol, glycopyrronium | Breztri aerosphere | 160 micrograms | Astrazeneca Pharmaceuticals (Pty) Ltd | 590375 | S4 |
2 more registered products name Glycopyrronium in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Glycopyrronium, neostigmine metilsulfate | Cholstyq | 0,5 mg, 2,5 mg | Umsebe healthcare | 560094 | S4 |
| Glycopyrronium, phenobarbitone Cancelled | Robunil-ph | Not stated | A H Robins Co (SA) (Pty) Ltd* | C0560 |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Glycopyrronium
S3: Glycopyrronium
Consolidated Schedules 06 July 2026, line 3691
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.